Leonid Timashev
Stock Analyst at RBC Capital
(4.91)
# 226
Out of 4,495 analysts
462
Total ratings
62.3%
Success rate
27.9%
Average return
Main Sectors:
Stocks Rated by Leonid Timashev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALKS Alkermes | Maintained: Buy | $56 | $53.78 | +4.13% | 21 | Jul 7, 2026 | |
| CRMD CorMedix | Maintained: Buy | $14 → $13 | $8.67 | +49.94% | 15 | Jul 7, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $119 → $117 | $86.07 | +35.94% | 22 | Jul 7, 2026 | |
| EXEL Exelixis | Maintained: Hold | $43 → $46 | $57.10 | -19.44% | 16 | Jul 7, 2026 | |
| INSM Insmed | Maintained: Buy | $195 | $118.26 | +64.89% | 23 | Jul 7, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $258 | $246.91 | +4.49% | 12 | Jul 7, 2026 | |
| VSTM Verastem | Maintained: Buy | $15 → $14 | $5.40 | +159.26% | 14 | Jul 7, 2026 | |
| AXSM Axsome Therapeutics | Maintained: Buy | $302 → $304 | $248.95 | +22.11% | 38 | Jul 7, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $436 → $451 | $302.83 | +48.93% | 15 | Jul 7, 2026 | |
| IDYA IDEAYA Biosciences | Maintained: Buy | $53 → $48 | $37.28 | +28.76% | 11 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $1.30 | +53.85% | 17 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $64 → $63 | $27.38 | +130.09% | 44 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $13.60 | +61.76% | 17 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $19 | $6.11 | +210.97% | 11 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.64 | +89.39% | 17 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 → $51 | $35.92 | +41.98% | 26 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $81 | $73.32 | +10.47% | 10 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $182 | $191.13 | -4.78% | 12 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $16.79 | +31.03% | 30 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $449 | $333.12 | +34.79% | 1 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 → $59 | $48.35 | +22.03% | 39 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $20 | $15.42 | +29.70% | 24 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $0.5814 | +416.00% | 7 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $3.17 | +341.64% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $16.12 | +17.90% | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5 | $4.18 | +19.62% | 4 | Apr 30, 2026 |
Alkermes
Jul 7, 2026
Maintained: Buy
Price Target: $56
Current: $53.78
Upside: +4.13%
CorMedix
Jul 7, 2026
Maintained: Buy
Price Target: $14 → $13
Current: $8.67
Upside: +49.94%
Cytokinetics
Jul 7, 2026
Maintained: Buy
Price Target: $119 → $117
Current: $86.07
Upside: +35.94%
Exelixis
Jul 7, 2026
Maintained: Hold
Price Target: $43 → $46
Current: $57.10
Upside: -19.44%
Insmed
Jul 7, 2026
Maintained: Buy
Price Target: $195
Current: $118.26
Upside: +64.89%
Jazz Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $258
Current: $246.91
Upside: +4.49%
Verastem
Jul 7, 2026
Maintained: Buy
Price Target: $15 → $14
Current: $5.40
Upside: +159.26%
Axsome Therapeutics
Jul 7, 2026
Maintained: Buy
Price Target: $302 → $304
Current: $248.95
Upside: +22.11%
BeOne Medicines AG
Jul 7, 2026
Maintained: Buy
Price Target: $436 → $451
Current: $302.83
Upside: +48.93%
IDEAYA Biosciences
Jul 7, 2026
Maintained: Buy
Price Target: $53 → $48
Current: $37.28
Upside: +28.76%
Jul 7, 2026
Maintained: Hold
Price Target: $2
Current: $1.30
Upside: +53.85%
Jul 7, 2026
Maintained: Buy
Price Target: $64 → $63
Current: $27.38
Upside: +130.09%
Jul 7, 2026
Maintained: Buy
Price Target: $22
Current: $13.60
Upside: +61.76%
Jul 7, 2026
Maintained: Buy
Price Target: $20 → $19
Current: $6.11
Upside: +210.97%
Jul 7, 2026
Maintained: Buy
Price Target: $5
Current: $2.64
Upside: +89.39%
Jun 30, 2026
Maintained: Buy
Price Target: $47 → $51
Current: $35.92
Upside: +41.98%
Jun 30, 2026
Maintained: Buy
Price Target: $81
Current: $73.32
Upside: +10.47%
Jun 26, 2026
Maintained: Buy
Price Target: $182
Current: $191.13
Upside: -4.78%
Jun 25, 2026
Maintained: Buy
Price Target: $22
Current: $16.79
Upside: +31.03%
Jun 17, 2026
Initiated Coverage: Buy
Price Target: $449
Current: $333.12
Upside: +34.79%
Jun 17, 2026
Rated: Buy
Price Target: $48 → $59
Current: $48.35
Upside: +22.03%
May 18, 2026
Maintained: Buy
Price Target: $14 → $20
Current: $15.42
Upside: +29.70%
May 14, 2026
Maintained: Hold
Price Target: $4 → $3
Current: $0.5814
Upside: +416.00%
May 11, 2026
Maintained: Buy
Price Target: $14
Current: $3.17
Upside: +341.64%
May 5, 2026
Maintained: Buy
Price Target: $19
Current: $16.12
Upside: +17.90%
Apr 30, 2026
Maintained: Hold
Price Target: $7 → $5
Current: $4.18
Upside: +19.62%